Doseology Announces Proposed Shares-for-Debt Settlement and Resignation of Director
Why now
Thesis: Micro-cap settles debt with equity, director exits
Catalyst to watch: Completion of settlement and new filings
Main risk: Share issuance dilutes existing holders
Why it matters
Shares-for-debt settlement and director resignation at a micro-cap signal balance-sheet stress and governance churn.
Details
KELOWNA, BC, Sept. 23, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it proposes to issue an...
Related assets & topics
ConsumerHealthcareSources
- prnewswire · 2026-09-23 22:16 UTC